Skip to main content

Menopause Hormone Therapy: Who Should Avoid It and Why?

Menopause Hormone Therapy Who Should Avoid It and Why

Menopause hormone therapy is not appropriate for every woman, and specific medical conditions make it genuinely risky rather than simply a matter of personal preference. For the majority of healthy women within ten years of menopause onset, current evidence shows the benefits of HRT generally outweigh the risks, but a smaller group of women fall into categories where the risk profile shifts meaningfully, and knowing which group you’re in matters more than general reassurance either way.

This isn’t about fear-mongering around HRT, which has been extensively studied and is safe for most women. It’s about being precise on the specific situations where it needs to be avoided or approached very differently.

Who Should Generally Avoid Hormone Therapy

A personal history of breast cancer. Since many breast cancers are hormone-sensitive, systemic HRT is generally avoided in women with a personal history of breast cancer, as it could theoretically stimulate recurrence. This is one of the clearest and most consistently applied contraindications.

A history of estrogen-dependent cancers. Beyond breast cancer, certain other hormone-sensitive cancers, including some types of endometrial cancer, generally rule out systemic hormone therapy for similar reasons.

Unexplained vaginal bleeding. Starting HRT without first investigating unexplained bleeding can mask or delay diagnosis of an underlying problem, including endometrial cancer, which is why this always needs evaluation before hormone therapy begins, not after.

A history of blood clots (DVT or pulmonary embolism). Oral estrogen in particular raises clotting risk, and women with a personal history of blood clots are generally advised against oral HRT, though transdermal (patch or gel) estrogen carries a notably lower clotting risk and may still be an option for some women in this category, under specialist guidance.

A history of stroke or heart attack. Starting HRT after an existing cardiovascular event carries increased risk and is generally avoided, particularly if started more than ten years after menopause onset.

Active liver disease. Since hormones are processed through the liver, significant active liver disease is a standard reason to avoid or carefully reconsider hormone therapy.

Uncontrolled high blood pressure. This doesn’t rule out HRT permanently, but blood pressure typically needs to be brought under control first before starting hormone therapy safely.

Pregnancy, or the possibility of it. This applies mainly to women in perimenopause who may still be fertile, where hormone therapy isn’t a form of contraception and pregnancy needs to be ruled out or prevented separately.

Where the Decision Is More Nuanced, Not a Flat No

Some situations aren’t outright contraindications but require a more careful, individualised conversation. A strong family history of breast cancer without a personal history, migraine with aura, well-controlled diabetes, and a higher body mass index all fall into this category, where the decision depends on the fuller clinical picture rather than a blanket rule. This is exactly why a proper medical history review matters more than a general checklist, and why self-starting or stopping HRT without that review isn’t the safest approach.

What Helps Instead, for Women Who Can’t Take Systemic HRT

Local vaginal estrogen for genitourinary symptoms. For vaginal dryness and related urinary symptoms specifically, low-dose local vaginal estrogen carries a very different, much lower risk profile than systemic HRT and is considered safe for many women who can’t take systemic hormone therapy, including some with a history of breast cancer, though this still needs individual medical confirmation.

Non-hormonal medications for hot flushes. Certain antidepressant classes, used at lower doses than for depression, and a newer category of non-hormonal medication specifically developed for hot flushes, can meaningfully reduce vasomotor symptoms without hormonal exposure.

Cognitive behavioural therapy for menopause symptoms. CBT has reasonable evidence specifically for reducing the distress and impact of hot flushes and improving sleep and mood during menopause, independent of hormone use.

Lifestyle measures. Regular exercise, reducing alcohol and caffeine, maintaining a stable weight, and good sleep hygiene won’t replace HRT’s effectiveness for moderate to severe symptoms, but they provide a meaningful, low-risk foundation regardless of which other treatment path is chosen.

Myth: HRT Is Universally Risky and Best Avoided by Everyone

This belief traces back largely to an early 2000s study that was widely misinterpreted in media coverage. More recent, more precise analysis shows that for most healthy women starting HRT within ten years of menopause, the risk profile is considerably more favourable than that early narrative suggested. The real nuance is knowing which specific group you fall into, not applying a blanket rule either way.

FAQs

If I have a family history of breast cancer but no personal history, can I still take HRT?

This is usually possible but needs an individualised risk discussion with your doctor, since family history raises risk without being an automatic contraindication the way a personal history is.

Can I take HRT if I had a blood clot many years ago?

It depends on the type of clot, what caused it, and whether the risk factor is still present. Transdermal estrogen may be an option in some cases, but this absolutely needs specialist input rather than a self-directed decision.

Does stopping HRT after years of use come with its own risks?

Stopping can bring a return of menopause symptoms, sometimes intensely, but there’s no inherent additional medical risk from stopping itself. Doing it gradually rather than abruptly tends to reduce symptom rebound for most women.

Is there an age limit after which HRT should never be started?

There’s no absolute cutoff, but starting HRT more than ten years after menopause onset, or after age sixty, is generally associated with a less favourable risk profile, particularly for cardiovascular risk, and needs a more cautious individual assessment.

If you’re weighing whether hormone therapy is right for you, particularly with any of the conditions above in the picture, book a consultation to go through it properly rather than guessing.

More Articles